174 related articles for article (PubMed ID: 36367870)
1. What does it mean to be affiliated with care?: Delphi consensus on the definition of "unaffiliation" and "specialist" in sickle cell disease.
Lamont AE; Hsu LL; Jacobs S; Gibson R; Treadwell M; Chen Y; Lottenberg R; Axelrod K; Varughese T; Melvin C; Smith S; Chukwudozie IB; Kanter J;
PLoS One; 2022; 17(11):e0272204. PubMed ID: 36367870
[TBL] [Abstract][Full Text] [Related]
2. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
3. Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).
Baumann AA; Belle SH; James A; King AA;
BMC Health Serv Res; 2018 Jun; 18(1):500. PubMed ID: 29945631
[TBL] [Abstract][Full Text] [Related]
4. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.
Smeltzer MP; Howell KE; Treadwell M; Preiss L; King AA; Glassberg JA; Tanabe P; Badawy SM; DiMartino L; Gibson R; Kanter J; Klesges LM; Hankins JS;
BMJ Open; 2021 Nov; 11(11):e050880. PubMed ID: 34789492
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
6. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
7. Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel.
Sharma D; Kozanoğlu I; Ataga KI; Benachi A; Büyükkurt S; Lanzkron S; Ozdogu H; Pancham S; Pecker LH; Robinson SE; Yilmaz Baran S; Howard J
Blood Adv; 2024 Feb; 8(4):1018-1029. PubMed ID: 38206762
[TBL] [Abstract][Full Text] [Related]
8. Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.
Hankins JS; Shah N; DiMartino L; Brambilla D; Fernandez ME; Gibson RW; Gordeuk VR; Lottenberg R; Kutlar A; Melvin C; Simon J; Wun T; Treadwell M; Calhoun C; Baumann A; Potter MB; Klesges L; Bosworth H;
JMIR Res Protoc; 2020 Jul; 9(7):e16319. PubMed ID: 32442144
[TBL] [Abstract][Full Text] [Related]
9. Perspectives of individuals with sickle cell disease on barriers to care.
Phillips S; Chen Y; Masese R; Noisette L; Jordan K; Jacobs S; Hsu LL; Melvin CL; Treadwell M; Shah N; Tanabe P; Kanter J
PLoS One; 2022; 17(3):e0265342. PubMed ID: 35320302
[TBL] [Abstract][Full Text] [Related]
10. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care.
Kanter J; Gibson R; Lawrence RH; Smeltzer MP; Pugh NL; Glassberg J; Masese RV; King AA; Calhoun C; Hankins JS; Treadwell M
JAMA Netw Open; 2020 May; 3(5):e206016. PubMed ID: 32469413
[TBL] [Abstract][Full Text] [Related]
11. Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.
Hulbert ML; Manwani D; Meier ER; Alvarez OA; Brown RC; Callaghan MU; Campbell AD; Coates TD; Frei-Jones MJ; Hankins JS; Heeney MM; Hsu LL; Lebensburger JD; Quinn CT; Shah N; Smith-Whitley K; Thornburg C; Kanter J
Pediatr Blood Cancer; 2023 Jan; 70(1):e29961. PubMed ID: 36094289
[TBL] [Abstract][Full Text] [Related]
12. Preoperative blood transfusions for sickle cell disease.
Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
[TBL] [Abstract][Full Text] [Related]
13. Blood bank management of sickle cell patients at comprehensive sickle cell centers.
Afenyi-Annan A; Willis MS; Konrad TR; Lottenberg R
Transfusion; 2007 Nov; 47(11):2089-97. PubMed ID: 17958539
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
Dexter D; McGann PT
Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
[TBL] [Abstract][Full Text] [Related]
16. Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004-2019.
Tang AY; Zhou M; Maillis AN; Lai KW; Lane PA; Snyder AB
Pediatr Blood Cancer; 2023 Mar; 70(3):e30152. PubMed ID: 36579749
[TBL] [Abstract][Full Text] [Related]
17. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
18. Attitudes of Primary Care Physicians Toward Sickle Cell Disease Care, Guidelines, and Comanaging Hydroxyurea With a Specialist.
Lunyera J; Jonassaint C; Jonassaint J; Shah N
J Prim Care Community Health; 2017 Jan; 8(1):37-40. PubMed ID: 27506442
[TBL] [Abstract][Full Text] [Related]
19. Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.
Isa H; Okocha E; Adegoke SA; Nnebe-Agumadu U; Kuliya-Gwarzo A; Sopekan A; Ofakunrin AO; Ugwu N; Hassan AA; Ohiaeri C; Madu A; Diaku-Akinwumi I; Ekwem L; Dogara LG; Okoh D; Jasini J; Girei A; Ekwere T; Okolo A; Kangiwa U; Lawson J; Chianumba R; Brown B; Akinola N; Nwegbu M; Nnodu O
Front Genet; 2023; 14():1052444. PubMed ID: 36816043
[No Abstract] [Full Text] [Related]
20. A Needs Assessment of Persons With Sickle Cell Disease in a Major Medical Center in North Carolina.
Masese RV; Crego N; Douglas C; Rains G; Bonnabeau E; DeMartino T; Shah N; Tanabe P
N C Med J; 2021; 82(5):312-320. PubMed ID: 34544765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
